0001127602-18-012374.txt : 20180321
0001127602-18-012374.hdr.sgml : 20180321
20180321160156
ACCESSION NUMBER: 0001127602-18-012374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180319
FILED AS OF DATE: 20180321
DATE AS OF CHANGE: 20180321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 18704463
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-03-19
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
Chairman & CEO
Common Stock
2018-03-19
4
M
0
21512
52.65
A
21652
D
Common Stock
2018-03-19
4
S
0
21390
110.0254
D
262
D
Common Stock
2018-03-19
4
S
0
122
111.6077
D
140
D
Common Stock
2018-03-20
4
M
0
301
52.65
A
441
D
Common Stock
2018-03-20
4
S
0
100
110.44
D
341
D
Common Stock
2018-03-20
4
S
0
100
110.48
D
241
D
Common Stock
2018-03-20
4
S
0
100
110.52
D
141
D
Common Stock
2018-03-20
4
S
0
1
111.10
D
140
D
Common Stock
683489
I
By Trusts
Stock Options
52.65
2018-03-19
4
M
0
21512
0
D
2009-12-31
2019-12-31
Common Stock
21512
301171
D
Stock Options
52.65
2018-03-20
4
M
0
301
0
D
2009-12-31
2019-12-31
Common Stock
301
300870
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
This transaction was executed in multiple trades at prices ranging from $110.00 to $110.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $111.375 to $111.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2018-03-21